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Abstract
Background: The application of mobile computing and communication technology is rapidly expanding in the
fields of health care and public health. This systematic review will summarise the evidence for the effectiveness of
mobile technology interventions for improving health and health service outcomes (M-health) around the world.
Findings: To be included in the review interventions must aim to improve or promote health or health service use
and quality, employing any mobile computing and communication technology. This includes: (1) interventions
designed to improve diagnosis, investigation, treatment, monitoring and management of disease; (2) interventions
to deliver treatment or disease management programmes to patients, health promotion interventions, and
interventions designed to improve treatment compliance; and (3) interventions to improve health care processes
e.g. appointment attendance, result notification, vaccination reminders.
A comprehensive, electronic search strategy will be used to identify controlled studies, published since 1990, and
indexed in MEDLINE, EMBASE, PsycINFO, Global Health, Web of Science, the Cochrane Library, or the UK NHS
Health Technology Assessment database. The search strategy will include terms (and synonyms) for the following
mobile electronic devices (MEDs) and a range of compatible media: mobile phone; personal digital assistant (PDA);
handheld computer (e.g. tablet PC); PDA phone (e.g. BlackBerry, Palm Pilot); Smartphone; enterprise digital assistant;
portable media player (i.e. MP3 or MP4 player); handheld video game console. No terms for health or health ser-
vice outcomes will be included, to ensure that all applications of mobile technology in public health and health
services are identified. Bibliographies of primary studies and review articles meeting the inclusion criteria will be
searched manually to identify further eligible studies. Data on objective and self-reported outcomes and study
quality will be independently extracted by two review authors. Where there are sufficient numbers of similar inter-
ventions, we will calculate and report pooled risk ratios or standardised mean differences using meta-analysis.
Discussion: This systematic review will provide recommendations on the use of mobile computing and
communication technology in health care and public health and will guide future work on intervention
development and primary research in this field.
Background
M-health, the use of mobile computing and communica-
tion technologies in health care and public health, is a
rapidly expanding area of research and practice.
M-health programmes and interventions use mobile
electronic devices (MEDs), such as personal digital assis-
tants (PDAs) and mobile phones, for a range of
functions from clinical decision support systems and
data collection tools for healthcare professionals [1,2], to
supporting health behaviour change and chronic disease
management by patients in the community [3].
Current documented M-health interventions and pro-
grammes include: mobile phone text messaging to sup-
port management of diabetes, hypertension, asthma,
eating disorders and HIV treatment [3-7]; mobile phone
text messaging and PDAs as aids to smoking cessation,
body weight loss, reducing alcohol consumption, sexu-
ally transmitted infection prevention and testing [3,5-7];
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research [1,8-10] and to support medical education and
clinical practice [2,11-13]. Whilst the majority of M-
health interventions are reported from high income
countries, there is an emerging literature on the applica-
tion of mobile technologies in low income countries
[1,7,14-16].
Mobile communication technology is the fastest grow-
ing sector of the communications industry in low
income countries [17,18]. In the last two decades, the
global digital divide has narrowed most for mobile
phone use, with many low income countries “leap-frog-
ging” over fixed-line communications technologies,
straight to expansion of wireless cellular communication
networks [18-20]. Whilst wireless communication net-
work coverage and mobile phone ownership are not
universal, or equally distributed, in low income coun-
tries, and the technology accessible to most of the popu-
lation lags far behind that available in high income
countries [19,21], there is still huge potential for M-
health interventions and programmes to have positive
effects on health outcomes in resource-poor settings
[15].
Mobile technologies have a number of key features
that give them an advantage over other information and
communication technologies in particular activities
within health care and public health. Firstly, many
MEDs have wireless cellular communication capability,
providing the potential for continuous, interactive com-
munication from any location e.g. telephone calls, text
and multimedia messaging and also internet access via
Wireless Application Protocol (WAP) or mobile broad-
band internet. Secondly, the devices are portable
because of their small size, low weight and rechargeable,
long-life battery power. Finally, many MEDs have suffi-
cient computing power to support multimedia software
applications. The combination of these features varies
between specific devices and their relative importance
will change with the health activity in which they are
used. However, with advances in technology develop-
ment, single devices increasingly possess many or all of
these functions.
Existing systematic reviews of M-health interventions,
and recently published protocols [22-26], focus on the
application of specific devices (e.g. mobile phones
[6,9,10,13,27]) or specific functions (e.g. text messaging
[3,4,28]) to individual diseases or healthcare fields (e.g.
diabetes care or chronic disease management [5,10,28]).
In this systematic review, we propose to look all types
of mobile technologies and all health outcomes, to pro-
vide a broad overview of the M-health sector at this
relatively early point in its development. This will allow
us to describe the use of different mobile technology
functions across a range of healthcare and public health
fields, from health behaviour to clinical outcomes such
as medication compliance and service use, both to high-
light similarities in mechanisms of action for a particular
device or function and to suggest where they may be
usefully transferred to new areas. Finally, we will identify
studies of newer technologies such as Smartphones and
portable media players, which are unlikely to be cap-
tured in technology-specific reviews.
The objectives of this review are to: (1) describe the
uses of mobile computing and communication technolo-
gies by patients, healthcare professionals and the general
public in the context of health service and public health
interventions that have been evaluated in controlled stu-
dies; (2) assess the effectiveness of mobile technologies
for improving health and health service outcomes in
high, middle and low income countries; and (3) describe
the acceptability of mobile technologies to patients,
healthcare professionals and the general public, in the
context of health service and health promotion
interventions.
Methods and Design
Review Inclusion Criteria
Types of technology
For the purposes of this review, MEDs will be defined as
devices which either have interactive wireless cellular
communication capability and/or those which run soft-
ware applications and are highly portable. We will there-
fore include interventions using: mobile phones;
personal digital assistants (PDA) and PDA phones (e.g.
BlackBerry, Palm Pilot); Smartphones (e.g. the iphone);
Enterprise digital assistants (EDA); portable media
players (i.e. MP3-players and MP4-players, e.g. ipod);
handheld video-game consoles (e.g. Playstation Portable
(PSP), Nintendo DS); handheld and ultra-portable com-
puters such as tablet PCs (e.g. the ipad) and Smart-
books. A summary of the functions available with each
of these devices is provided in Table 1. Desktop perso-
nal computers, notebook (laptop) computers, subnote-
book computers, netbooks, pagers, handheld calculators
and pedometers are not considered to be MEDs and
interventions delivered exclusively on these devices will
be excluded. Whilst notebook computers are designed
to be portable we have excluded them from this review
because, in comparison to MEDs as defined above, note-
book computers: (1) have substantially shorter battery
life; (2) weigh substantially more; (3) do not provide
quick access to information and programmes (PDAs
and mobile phones have “always on” functionality); and
(4) are not suitable for healthcare activities that require
the user to be standing or mobile.
Types of intervention
Interventions must aim to improve or promote health or
health service use and quality, employing any MED.
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diagnosis, investigation, treatment, monitoring and man-
agement of disease; (2) interventions to deliver treat-
ment or disease management programmes to patients,
health promotion interventions, and interventions
designed to improve treatment compliance; and (3)
interventions to improve health care processes e.g.
appointment attendance, result notification, vaccination
reminders. We will therefore include:
- Any intervention delivered using an MED owned
or directly used by a patient or lay person;
- Any clinical or practice aid delivered using an
MED owned or directly used by a healthcare
professional;
- Any data collection or storage for the purposes of
healthcare or health research using an MED.
We anticipate that interventions will aim to address
one of the health domains shown in Figure 1, although
it is likely that further MED applications will be identi-
fied in the review and this framework will be updated.
Types of studies
Studies must have used a controlled design to evaluate
an MED intervention. We will include both randomised
controlled trials and studies with non-random treatment
group allocation. Previous reviews have highlighted the
difficulty in assessing the impact of MED on health out-
c o m e sw h e nt h eM E Di su s e da sa na d j u n c tt oo t h e r
interventions and services e.g. text messaging in addition
to clinician appointments for managing hypertension
[4]. We will therefore only include studies where the
MED is the primary intervention component under eva-
luation. We will include studies evaluating:
- Interventions delivered via a single MED to the
treatment group (N.B. this could therefore include
an intervention where a number of behaviour change
techniques are used, e.g. prompts, reminders and
patient-initiated support, but all delivered through a
single MED, e.g. SMS to and from a mobile phone),
where the control group receives no MED
intervention;
- Multi-MED interventions where the treatment
group receives one or more interventions delivered
through multiple MED, but no interventions through
other (non-MED) modes and the control group
receives no MED interventions;
- Mixed MED and non-MED interventions where
the treatment and control group both receive all
non-MED components of the intervention and the
MED intervention is delivered only to the treatment
group, e.g. SMS plus group counselling for smoking
cessation in the treatment group and the control
group receives group counselling only;
- Interventions delivered by different MED e.g.
iphone vs. regular mobile phone;
- The features and components of interventions
delivered on a particular MED, such as the intensity,
personalisation, content, duration and timing of an
intervention, and the degree of software or other
component customisation.
We will exclude studies evaluating:
- Mixed MED and non-MED interventions where
the treatment and control group both receive the
MED component;
Table 1 Functions of mobile electronic devices included in the review
Mode of communication
Voice SMS MMS Email WAP
internet
Wireless cellular
broadband
Audio Video Custom/additional software
support
Mobile phone
Basic model
1
(e.g. Nokia 1280)
1 ✓✓
High-end model
1
(e.g. Nokia 6303i)
1 ✓✓✓✓ ✓ ✓ ✓
PDA ✓✓✓✓ (✓) ✓
Smartphone ✓✓✓✓ ✓ ✓ ✓
PDA phone ✓✓ ✓ ✓
Enterprise digital assistant ✓
Portable media player ✓✓
Handheld video games
console
✓✓
Brackets indicate where functions are available on only some higher specification models.
Abbreviations: MMS, multimedia messaging service; PDA, personal digital assistant; SMS, short messaging service; WAP, wireless application protocol.
1Source GSM Arena (http://www.gsmarena.com/, accessed 09.06.10).
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ferences between the treatment and control groups
besides the delivery of the MED component(s).
Types of participants
There will be no limits on study participants in terms of
age, gender, ethnicity, morbidities (for patients and the
general population) or staff role and occupation (for
healthcare professionals e.g. nurse, surgeon, or phy-
siotherapist). There will be no limits on study setting
and we will include studies at all levels of healthcare set-
ting (i.e. primary, secondary and tertiary healthcare) and
those conducted in the community.
Types of outcome measures
All outcome measures reported in studies meeting the
inclusion criteria will be extracted, both objective and self-
reported measures. User-acceptability will be assessed as a
self-reported outcome for all intervention types. We will
also seek data on unintended adverse consequences of the
interventions and process outcomes (e.g. repetitive strain
injury or involvement in road traffic accidents).
Primary outcome measures will include any objective
measure of health, or health service delivery or use. These
may include biologically confirmed smoking cessation or
mean change in body mass index, blood pressure, blood
lipids or blood glucose levels. Secondary outcome mea-
sures will include: cognitive outcomes relating to knowl-
edge, motivation, self-efficacy and intention; self-reported
outcomes related to health behaviours (e.g. number of
cigarettes smoked), chronic disease management, health
service delivery or use. Examples of outcome measures for
each health domain in Figure 1 are provided in Table 2.
Literature search
We will use a three-part search strategy to identify studies
meeting the inclusion criteria above that have been pub-
lished since 1990: (1) we will search electronic biblio-
graphic databases for published work, using a
comprehensive search strategy for mobile technology inter-
ventions; (2) we will search trial registers for ongoing and
recently completed trials; (3) we will search the reference
lists of primary studies included in the review and the
reference lists of relevant, previously published reviews.
Electronic bibliographic databases
The following electronic bibliographic databases will be
searched: MEDLINE, EMBASE, PsycINFO, Global
Health, The Cochrane Library (Cochrane Database of
Systematic Reviews, Cochrane Central Register of Con-
trolled Trials (CENTRAL), Cochrane Methodology Reg-
ister), NHS Health Technology Assessment Database,
and Web of Science (science and social science citation
index). The search strategy will include only terms relat-
ing to or describing mobile technologies because we will
include all types of intervention and health or health ser-
vice outcomes meeting the inclusion criteria described
above. The search strategy for MEDLINE is shown in
Additional File 1. All of these terms will be combined
with the Cochrane Library MEDLINE filter for controlled
trials of interventions. The mobile technology search
terms will be adapted for use with other bibliographic
databases in combination with database-specific filters
for controlled trials, where these are available. There will
be no language restrictions. The searches will be re-run
immediately prior to analysis and further studies
Figure 1 Conceptual framework for mobile electronic device intervention classification.
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information is presented in the review.
We will include data from dissertations that meet the
inclusion criteria, where these are indexed in the above
databases and retrieved in our search. We will not be
retrieving or including any unpublished data.
Trial registers
Ongoing, recently completed and unpublished clinical
trials meeting the inclusion criteria described above will
be identified from the following research registers:
National Institutes of Health clinical trials registry (US);
National Institute for Health Research Clinical Research
Network Portfolio Database (UK); National Research
Register Projects Database Archive (UK); and Current
Controlled Trials (includes the International Standard
Randomised Controlled Trial Number Register).
Study screening and selection
Titles and abstracts of studies retrieved using the search
strategy and those from additional sources will be
screened independently by two review authors to iden-
tify studies that potentially meet the inclusion criteria
outlined above. The full text of these potentially eligible
studies will be retrieved and independently assessed for
eligibility by two review authors. Any disagreement
between the two review authors over the eligibility of
particular studies will be resolved through discussion
with a third review author.
Data extraction
A standardised, pre-piloted form will be used to extract
data from the included studies for assessment of study
quality and evidence synthesis. Extracted information
will include: study setting (including country); study
population and participant demographics and baseline
characteristics; MED used; details of the intervention
and control conditions; study methodology; recruitment
and study completion rates; outcomes and times of mea-
surement; indicators of acceptability to users; suggested
mechanisms of intervention action; information for
Table 2 Example outcome measures for anticipated MED-based interventions shown in Figure 1
MED-based intervention Example outcome measures
Objective outcomes Self-reported outcomes
Clinical decision support systems -
diagnosis
￿ Adherence to clinical protocol
￿ Diagnosis of disease or disease risk (primary prevention)
￿ Treatment e.g. medication prescribed
￿ Use of clinical protocol
￿ Ease of clinical protocol use/
comprehensibility
Clinical decision support systems -
disease management
￿ Successful disease management e.g. diabetes control measured by
HbA1C, peak flow
￿ Medication prescribed
￿ Investigations arranged
￿ Health outcomes e.g, cardiac events, mortality, diarrhoea, breast feeding
￿ Use of clinical protocol
￿ Ease of clinical protocol use/
comprehensibility
Medical education ￿Changes in clinical knowledge/skills ￿ Ease of use
Disease monitoring ￿ Data collected
￿ Disease control e.g. HbA1c, peak flow
￿ Timeliness of data collection
￿ Ease of data collection
Data collection tools
Medical records
￿ Data completeness
￿ Timeliness of data collection
￿ Ease of data collection
￿ Ease of diagnosis
Test result notification ￿ Time to result notification
￿ Time to treatment initiation
￿ Patient satisfaction with clinic
service
￿ Clinician preference for mode of
notification
Appointment reminders ￿ Percent of appointments missed
￿ Percentage of appointments cancelled in advance
￿ Patient intention to attend
appointment
Treatment programmes ￿ Treatment outcomes e.g. change in depression score ￿ Patient satisfaction with treatment
￿ Perceived level of support
￿ Perceived changes in health
status/disease condition
Chronic disease management
Medication adherence
￿ Disease management e.g. diabetes control measured by HbA1C or
asthma management expiration peak flow rate
￿ Percent of medication doses taken on time
￿ Self-efficacy to manage
condition/medication
Health behaviour change ￿ Health outcome e.g. body mass index (weight loss) or blood cotinine
levels (smoking cessation)
￿ Self-efficacy to increase exercise/
control dietary intake
￿ Self reported behaviour
Acute disease management (first
aid/emergency care)
￿ Cardiopulmonary resuscitation chest compression rate/depth/accuracy/
hand position
￿ Perceived clarity of instructions
Untargeted mass health promotion
campaigns
￿ Coverage
￿ Uptake of services or treatment
￿ Knowledge
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authors will independently extract data, discrepancies
will be identified and resolved through discussion (with
a third author where necessary). Missing data will be
requested from study authors via email.
Assessing risk of bias
Two review authors will independently assess the risk of
bias in included studies by considering the following
characteristics, as recommended by the International
Cochrane Collaboration [29]:
- Randomisation sequence generation: was the allo-
cation sequence (used to assign participants to the
treatment and control groups) adequately generated?
(This criterion only applies to randomised controlled
trials.)
- Treatment allocation concealment: was the allo-
cated treatment adequately concealed from study
participants and clinicians and other healthcare or
research staff at the enrolment stage?
- Blinding: were the personnel assessing outcomes
and analysing data sufficiently blinded to the inter-
vention allocation throughout the trial?
- Completeness of outcome data: were participant
exclusions, attrition and incomplete outcome data
adequately addressed in the published report?
- Selective outcome reporting: is there evidence of
selective outcome reporting and might this have
affected the study results?
- Other sources of bias: was the trial apparently free
of any other problems that could produce a high
risk of bias?
Disagreements between the review authors over the
risk of bias in particular studies will be resolved by dis-
cussion, with involvement of a third review author
where necessary. The level of risk of bias in each of
these domains will be presented separately for each
study in tables in the final review publication.
Analysis
Descriptive analysis
We will provide a narrative synthesis of the findings
from the included studies. We will structure the narra-
tive synthesis by describing the studies according to the
following characteristics:
- The type of intervention e.g. individual behaviour
change, chronic disease self-management, clinic
appointment reminders or clinical diagnostic aid (as
outlined in Figure 1);
- The type of MED used;
- The target population characteristics e.g. age, gen-
der, ethnicity, socioeconomic status and/or educa-
tion level, low/middle/high income country setting
(classified according to the World Bank List of
Economies [30]);
- The type of outcome e.g. smoking cessation or
weight loss;
- Intervention content - features of the MED
employed (e.g. SMS, video), intervention compo-
nents such as reminders, feedback or peer support,
intensity, duration, personalisation and theoretical
basis (if stated).
We will provide summaries of intervention effects for
each study by calculating risk ratios (for dichotomous
outcomes) or standardised mean differences (for contin-
uous outcomes) from the data presented in the pub-
lished studies or obtained from study authors.
Statistical analysis
We anticipate that there will be limited scope for meta-
analysis because of the range of different outcomes mea-
sured across the reasonably small number of existing
mobile technology intervention trials. However, where
studies have used the same type of intervention and
MED, with the same outcome measure, we will use
Stata v11.0 [31] to pool the results of randomised con-
trolled trials using a random-effects meta-analysis, with
standardised mean differences for continuous outcomes
and risk ratios for binary outcomes, and calculate 95%
confidence intervals and two sided P values for each
outcome. In studies where the effects of clustering have
not been taken into account, we will adjust the standard
deviations for the design effect, using intra-class coeffi-
cients, if they are provided in the study reports, or alter-
natively using external estimates obtained from similar
studies [32]. Heterogeneity between the studies in effect
measures will be assessed using both the c
2 test and the
I
2 statistic. We will consider an I
2 value greater than
50% indicative of substantial heterogeneity. We will con-
duct sensitivity analyses based on study quality (risk of
bias; level of participant drop-out) in order to investigate
possible sources of heterogeneity). We will use stratified
meta-analyses to explore heterogeneity in effect esti-
mates according to: study quality (allocation conceal-
ment and blinding in RCTs); study populations (primary
versus secondary prevention for health behaviour change
interventions and high versus low and middle income
country settings); the logistics of intervention provision
(fully automated intervention content versus content
generated by healthcare professionals or other qualified
personnel); and intervention content (information only
versus explicit use of behaviour change theories and
techniques for behaviour change interventions). We will
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weighted regression method for continuous outcomes
and Begg’s rank correlation test for dichotomous
outcomes.
Conclusion
This systematic review of M-health interventions will
provide a detailed summary of the evidence for the
effectiveness of mobile computing and communication
technologies to improve a broad range of health and
health service outcomes.
Additional material
Additional file 1: MEDLINE (Ovid) search strategy. Search terms used
to identify studies of interventions using mobile computing and
communication technologies in MEDLINE (Ovid).
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